Drug stocks mixed, Sequenom tanks on test delay
Drug stocks were mixed in early action Thursday as shares of biotech group Sequenom Inc. tanked on news that the launch of its new test for Down Syndrome will be delayed.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here